栗蘑(灰树花)切断肿瘤细胞再生之路

2017-7-17 14:49:22      点击:

摘要:Maitakedoesnotkillcancercellsdirectly.Itstimulatestheactivityofimmune-competentcellsandletsthemfightwithcancercells.Chemotherapyissupposedtokillcancercellsdirectly.Then,whichismoreeffectiveintermsof

 Maitake does not kill cancer cells directly. It stimulates the activity of immune-competent cells and lets them fight with cancer cells. Chemotherapy is supposed to kill cancer cells directly. Then, which is more effective in terms of cancer growth inhibition? At a recent cancer convention in San Diego (Adjuvant Nutrition in Cancer Treatment Symposium) sponsored by the Cancer Treatment Research Foundation, I had an opportunity to report some very interesting results from my study on this effect. I used Mitomycin C (MMC) on this test. MMC is probably the most popular antibiotic drug used among Japanese doctors (also being widely used in America) for various cancer treatments. It is known to be one of the strongest anticancer drugs having very severe side effects as well. In my animal, test, Maitake D-fraction, MMC, and both D-fraction and MMC (cutting each dose by half) were injected into tumor-bearing mice respectively。As you see the Table 4, D- fraction alone demonstrates superior tumor growth inhibition to that of MMC ( about 80% vs. 45%). When MMC and D-fraction were given together, cutting each dose by half, tumor inhibition was further enhanced (nearly 98%). The result indicates some synergistic effect between MMC and Maitake, i.e., tumor cells are directly attacked by MMC while the immune system is activated by D-fraction. Chemotherapy is sometimes very critical as it lowers the immune system of the patients significantly. For human cases, I have seen a lot of advanced cancer patients recovered from severe side effects, caused by chemotherapies, by taking Maitake D-fraction (orally) together. I would be very comfortable to say that Maitake and chemo work together, or that you should take Maitake when you have to take chemo.

灰树花是通过激活体内免疫细胞的活性来抑制或杀灭肿瘤细胞的。化疗抗癌药物被认为可以直接杀死癌细胞。那么,究竟谁在肿瘤生长期的抑制作用更强?在圣迭哥召开的癌症大会(癌症治疗中的辅助营养学研讨会)上,我有幸将我在这方面研究的一些很有意思的结果向大家做了介绍。在这个实验中,我选用了丝裂霉素,这种药在日本是医生广泛采用的抗生素类药物(在美国也是一种常用药),被用于许多癌症的治疗。丝裂霉素是目前已知的作用最为有效的抗癌药物之一,但是,具有非常大的副作用。在我所做的动物实验中,丝裂霉素、灰树花D组分以及丝裂霉素和灰树花D组分的混合物(均为单独用剂量的一半)分别注射小鼠,结果所示:灰树花D组分单独服用的肿瘤抑制率远远高于丝裂霉素,分别为80%和45%,而二者联合服用的肿瘤抑制率可以得到更大的提高,接近98%。以上结果表明,腹腔注射丝裂霉素和灰树花,丝裂霉素可以直接杀死癌细胞,而灰树花并不是直接杀死癌细胞,而是激活体内的免疫细胞,去攻击肿瘤细胞,从而阻止新生的癌细胞产生。我们都知道,化疗的限制非常的严格,因为它在很大程度上降低了病人的免疫系统功能。而在我接触的病例中,有许多例病人能通过口服灰树花而消除了化疗的这种副作用,在这里,我可以欣慰的说,灰树花和化疗药物可以共同作用,而且当你在不得不进行化疗的同时,应该服用灰树花。

(来源于网络)

栗蘑(灰树花)切断肿瘤细胞再生之路